X-17376088-TCGGCGGCGG-TCGGCGGCGGCGG
Position:
Variant summary
Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP6_Very_StrongBS2
The NM_001291867.2(NHS):c.348_350dup(p.Ala116dup) variant causes a inframe insertion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00013 in 1,078,419 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 36 hemizygotes in GnomAD. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.00027 ( 0 hom., 6 hem., cov: 23)
Exomes 𝑓: 0.00011 ( 0 hom. 30 hem. )
Consequence
NHS
NM_001291867.2 inframe_insertion
NM_001291867.2 inframe_insertion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.485
Genes affected
NHS (HGNC:7820): (NHS actin remodeling regulator) This gene encodes a protein containing four conserved nuclear localization signals. The encoded protein functions in eye, tooth, craniofacial and brain development, and it can regulate actin remodeling and cell morphology. Mutations in this gene have been shown to cause Nance-Horan syndrome, and also X-linked cataract-40. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, May 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -12 ACMG points.
BP6
Variant X-17376088-T-TCGG is Benign according to our data. Variant chrX-17376088-T-TCGG is described in ClinVar as [Likely_benign]. Clinvar id is 588878.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High Hemizygotes in GnomAd4 at 6 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NHS | NM_001291867.2 | c.348_350dup | p.Ala116dup | inframe_insertion | 1/9 | ENST00000676302.1 | NP_001278796.1 | |
NHS | NM_198270.4 | c.348_350dup | p.Ala116dup | inframe_insertion | 1/8 | NP_938011.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NHS | ENST00000676302.1 | c.348_350dup | p.Ala116dup | inframe_insertion | 1/9 | NM_001291867.2 | ENSP00000502262 | P4 | ||
NHS | ENST00000380060.7 | c.348_350dup | p.Ala116dup | inframe_insertion | 1/8 | 1 | ENSP00000369400 | A2 |
Frequencies
GnomAD3 genomes AF: 0.000272 AC: 30AN: 110366Hom.: 0 Cov.: 23 AF XY: 0.000180 AC XY: 6AN XY: 33338
GnomAD3 genomes
AF:
AC:
30
AN:
110366
Hom.:
Cov.:
23
AF XY:
AC XY:
6
AN XY:
33338
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000246 AC: 8AN: 32481Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 7751
GnomAD3 exomes
AF:
AC:
8
AN:
32481
Hom.:
AF XY:
AC XY:
0
AN XY:
7751
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000114 AC: 110AN: 968013Hom.: 0 Cov.: 31 AF XY: 0.0000977 AC XY: 30AN XY: 306963
GnomAD4 exome
AF:
AC:
110
AN:
968013
Hom.:
Cov.:
31
AF XY:
AC XY:
30
AN XY:
306963
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000272 AC: 30AN: 110406Hom.: 0 Cov.: 23 AF XY: 0.000180 AC XY: 6AN XY: 33392
GnomAD4 genome
AF:
AC:
30
AN:
110406
Hom.:
Cov.:
23
AF XY:
AC XY:
6
AN XY:
33392
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 28, 2017 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Nance-Horan syndrome Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 23, 2022 | - - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Feb 01, 2023 | NHS: BS2 - |
NHS-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Mar 14, 2023 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at